2


R. J. Kreitman et al.


the Hairy Cell Leukemia Consortium. The Hairy Cell Leukemia Research Foundation, which has supported HCL research for many years, was also represented at the meeting. The goals of the meeting were to 1) discuss standard treatments of HCL and evidence supporting their administration, 2) deter- mine needs and current and future opportunities for clinical research, 3) disseminate results of newer diagnostic techniques, 4) discuss recent advances in HCL biology, including the molecular characteriza- tion of HCL cells with implications for disease origin and prognosis, 5) discuss new treatments for relapsed and refractory disease, including investiga- tional agents, and 6) improve patient access to treatment and clinical trials. The meeting took place


on April 26–27, 2010 on the NIH campus and the program of this meeting is included in this issue of the journal. Many of the speakers who discussed HCL topics contributed a short version of their talks in a summary for this issue of Leukemia and Lymphoma. It is our combined hope that renewed energy from


this conference will lead to continuing basic and clinical research in this disease, stimulate the devel- opment of new strategies for improving the very long- term outcome of patients and encourage interna- tional co-operation in HCL worldwide. We look forward to progress in this field and hope that these workshops in HCL will become a permanent feature on our calendars in the years to come.


Robert Kreitman


Aaron Polliack


Michael Grever


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122